Nimbus Therapeutics
Eli Lilly Enters Second Collaboration with Nimbus Therapeutics in $55M Upfront Deal for Novel Oral Obesity Drug
Eli Lilly; Nimbus Therapeutics; obesity drug; $55M upfront; $1.3B deal; oral treatment; metabolic diseases
Actionable Insights Powered by AI
Eli Lilly; Nimbus Therapeutics; obesity drug; $55M upfront; $1.3B deal; oral treatment; metabolic diseases